|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3325509 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16744353.0 |
| Date of filing the European patent application | 2016-07-21 | |
| (97) | Date of publication of the European application | 2018-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
| (46) | Date of publication of the claims translation | 2021-06-10 |
| (86) | Number | PCT/EP2016/067465 |
| Date | 2016-07-21 |
| (87) | Number | WO 2017/013230 |
| Date | 2017-01-26 |
| (30) | Number | Date | Country code |
| 15306192 | 2015-07-22 | EP |
| (72) |
LAUNAY, Pierre, FR
BELANGER, Coralie, FR
SOUCHET, Hervé, FR
|
| (73) |
INATHERYS,
4 Rue Pierre Fontaine Pépiniere Génopole Entreprise Campus 1, 91058 Evry Cedex,
FR
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-TfR antikūnai ir jų panaudojimas proliferacinių ir uždegiminių sutrikimų gydymui |
| ANTI-TFR ANTIBODIES AND THEIR USE IN TREATING PROLIFERATIVE AND INFLAMMATORY DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 10 | 231.00 EUR |
| 2026-07-21 |